Skip to main content
. Author manuscript; available in PMC: 2019 Jul 29.
Published in final edited form as: Dev Psychopathol. 2018 Aug;30(3):773–785. doi: 10.1017/S0954579418000639

Figure 3.

Figure 3.

SRI-only use is associated with greater fetal movement. *At 24 weeks, the SRI Only group was significantly higher on fetal movement compared to the No Medication group (p = .02). **At 30 weeks, the SRI Only group was significantly higher on fetal movement compared to the No Medication, SRI +Non-SRI, and Non-SRI groups (p = .03, .03, and .05, respectively).